Cargando…

Establishment of a type II insulin-like growth factor receptor gene site-integrated SKBR3 cell line using CRISPR/Cas9

Human epidermal growth factor receptor 2 (HER-2)(+) breast cancer has a high recurrence rate and a poor prognosis, with drug resistance contributing to disease progression. The present study aimed to establish a SKBR3 cell line with type II insulin-like growth factor receptor (IGR-IIR) gene site int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xinyu, Cao, Ru, Xiao, Haiyan, Cao, Zhongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586281/ https://www.ncbi.nlm.nih.gov/pubmed/33123265 http://dx.doi.org/10.3892/ol.2020.12216

Ejemplares similares

Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
por: Tao, Jianli, et al.
Publicado: (2022)

Honokiol inhibits the growth of SKBR3 cells
por: Shi, He, et al.
Publicado: (2020)

Application of CRISPR/Cas9 System in Establishing Large Animal Models
por: Lin, Yingqi, et al.
Publicado: (2022)

CRISPR/Cas9 establishment-mediated targeted mutagenesis in Macrobrachium nipponense
por: Qiao, Hui, et al.
Publicado: (2023)

Establishment of CRISPR-Cas9 system in Bifidobacteria animalis AR668
por: Li, Jiao, et al.
Publicado: (2023)

CRISPR/Cas9-Mediated Gene Editing in Salmonids Cells and Efficient Establishment of Edited Clonal Cell Lines
por: Strømsnes, Trygve A. H., et al.
Publicado: (2022)

Establishment of a CRISPR/Cas9-based strategy for inducible protein dimerization
por: Zielich, Jeffrey, et al.
Publicado: (2018)

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
por: Cui, Zifeng, et al.
Publicado: (2022)

Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks
por: Lazar, Iulia M., et al.
Publicado: (2022)

Type II CRISPR/Cas9 approach in the oncological therapy
por: Biagioni, A., et al.
Publicado: (2017)

How Type II CRISPR-Cas establish immunity through Cas1-Cas2 mediated spacer integration
por: Xiao, Yibei, et al.
Publicado: (2017)

The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
por: Chylinski, Krzysztof, et al.
Publicado: (2013)

Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
por: Fang, Tianxu, et al.
Publicado: (2022)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Erratum: Establishment of a CRISPR/Cas9-based strategy for inducible protein dimerization
Publicado: (2019)

CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics
por: Lu, Jian, et al.
Publicado: (2021)

Establishment of CRISPR/Cas9 Genome Editing in Witloof (Cichorium intybus var. foliosum)
por: De Bruyn, Charlotte, et al.
Publicado: (2020)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Effect of GEN1 interference on the chemosensitivity of the breast cancer MCF-7 and SKBR3 cell lines
por: WU, YUNLU, et al.
Publicado: (2016)

Cas9 function and host genome sampling in Type II-A CRISPR–Cas adaptation
por: Wei, Yunzhou, et al.
Publicado: (2015)

Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems
por: Fonfara, Ines, et al.
Publicado: (2014)

Physiological Alterations in Deletion Mutants of Two Insulin-Like Peptides Encoded in Maruca vitrata Using CRISPR/Cas9
por: Al Baki, Md. Abdullah, et al.
Publicado: (2021)

Integrative Analysis of CRISPR/Cas9 Target Sites in the Human HBB Gene
por: Luo, Yumei, et al.
Publicado: (2015)

Machine learning in the estimation of CRISPR-Cas9 cleavage sites for plant system
por: Das, Jutan, et al.
Publicado: (2023)

Mutagenesis and homologous recombination in Drosophila cell lines using CRISPR/Cas9
por: Bassett, Andrew R., et al.
Publicado: (2013)

Unbiased proteomic mapping of the LINE-1 promoter using CRISPR Cas9
por: Briggs, Erica M., et al.
Publicado: (2021)

A fly model establishes distinct mechanisms for synthetic CRISPR/Cas9 sex distorters
por: Fasulo, Barbara, et al.
Publicado: (2020)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion
por: Alhaidan, Yazeid, et al.
Publicado: (2021)

Mobile CRISPR-Cas9 based anti-phage system in E. coli
por: Cao, Zhou, et al.
Publicado: (2022)

Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9
por: Jiang, Junfeng, et al.
Publicado: (2016)

PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing
por: Malina, Abba, et al.
Publicado: (2015)

Seamless site-directed mutagenesis of the Saccharomyces cerevisiae genome using CRISPR-Cas9
por: Biot-Pelletier, Damien, et al.
Publicado: (2016)

Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation
por: McDonald, James I., et al.
Publicado: (2016)

Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9
por: Khoshnejad, Makan, et al.
Publicado: (2018)

Photocontrol of CRISPR/Cas9 function by site-specific chemical modification of guide RNA
por: Wang, Yang, et al.
Publicado: (2020)

Acceleration of CRISPR/Cas9-Mediated Editing at Multiple Sites in the Saccharomyces cerevisiae Genome
por: Karpukhin, Alexey D., et al.
Publicado: (2023)

Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line
por: Fehling-Kaschek, Mirjam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d6m5uaejfv4rmmmpdiufe48mka